Pardridge W M, Mietus L J
J Clin Invest. 1980 Aug;66(2):367-74. doi: 10.1172/JCI109865.
The transport of [(125)I]thyroxine (T(4)) and [(125)I]triiodothyronine (T(3)) into liver was investigated with a tissue sampling-portal vein injection technique in the anesthetized rat. The method allows the investigation of the effects of plasma proteins in human serum on the unidirectional influx of T(4) or T(3) into liver cells. The percent extraction of unidirectional clearance of T(3) and T(4) was 77+/-2% and 43+/-2%, respectively, after portal injection of a bolus of Ringer's solution. Cell membrane transport of T(4) or T(3) was nonsaturable because 50-muM concentrations of unlabeled hormone had no effect on transport. The addition of bovine albumin in concentrations of 1, 5, or 10 g/100 ml bound >98% of T(4) or T(3) in vitro, but had no significant effect on T(3) or T(4) transport in vivo. Conversely, 10% rabbit antisera specific for T(3) or T(4), completely abolished the intracellular distribution of thyroid hormone into liver. In the presence of rat serum, which contains albumin and thyroid hormone binding pre-albumin (TBPA), 18 and 81% of total plasma T(4) and T(3), respectively, were available for transport in vivo. The fraction of hormone available for transport in the presence of normal human serum, which contains albumin, TBPA, and thyroid hormone binding globulin (TBG) was 11% for T(4) and 72% for T(3). The fraction of hormone transported into liver after injection of serum obtained from pregnant or birth control pilltreated volunteers was 4% for T(4) (but this was not significantly different from zero) and 54% for T(3). THESE DATA SUGGEST: (a) The mechanism by which T(4) and T(3) traverse the liver cell membrane is probably free diffusion. (b) Albumin-bound T(4) or T(3) is freely cleared by liver, approximately 50% of TBG-bound T(3) is transported, but little, if any, of TBPA-bound T(4) or TBG-bound T(4) is cleared by liver cells. (c) Although the albumin-bound fraction of T(4) greatly exceeds the free (dialyzable) moiety, the two fractions are both inversely related to the existing TBA or TBG level; therefore, in vitro measurements of free T(4) would be expected to accurately reflect what is available for transport in vivo. Conversely, TBG-bound T(3) is readily transported in vivo; therefore, it is proposed that in vitro measurements of free T(3) do not reliably predict the fraction of T(3) available for transport into liver in vivo.
采用组织取样 - 门静脉注射技术,在麻醉大鼠中研究了[(125)I]甲状腺素(T(4))和[(125)I]三碘甲状腺原氨酸(T(3))向肝脏的转运。该方法可用于研究人血清中的血浆蛋白对T(4)或T(3)单向流入肝细胞的影响。门静脉注射大剂量林格氏液后,T(3)和T(4)的单向清除率分别为77±2%和43±2%。T(4)或T(3)的细胞膜转运是非饱和的,因为50 μM浓度的未标记激素对转运没有影响。体外添加浓度为1、5或10 g/100 ml的牛血清白蛋白可结合>98%的T(4)或T(3),但对体内T(3)或T(4)的转运没有显著影响。相反,10%针对T(3)或T(4)的兔抗血清完全消除了甲状腺激素在肝脏中的细胞内分布。在含有白蛋白和甲状腺激素结合前白蛋白(TBPA)的大鼠血清存在下,血浆中总T(4)和T(3)分别有18%和81%可用于体内转运。在含有白蛋白、TBPA和甲状腺激素结合球蛋白(TBG)的正常人血清存在下,可用于转运的激素分数,T(4)为11%,T(3)为72%。注射从怀孕或服用避孕药的志愿者获得的血清后,转运到肝脏中的激素分数,T(4)为4%(但与零无显著差异),T(3)为54%。这些数据表明:(a)T(4)和T(3)穿过肝细胞膜的机制可能是自由扩散。(b)与白蛋白结合的T(4)或T(3)可被肝脏自由清除,约50%与TBG结合的T(3)被转运,但肝细胞清除与TBPA结合的T(4)或与TBG结合的T(4)很少,如果有的话。(c)尽管与白蛋白结合的T(4)部分大大超过游离(可透析)部分,但这两部分均与现有的TBA或TBG水平呈负相关;因此,预计体外测量游离T(4)能准确反映体内可用于转运的物质。相反,与TBG结合的T(3)在体内易于转运;因此,有人提出体外测量游离T(3)不能可靠地预测体内可用于转运到肝脏的T(3)分数。